首页> 外文期刊>Acta medica Okayama >Effects of Switching from Treatment with Amlodipine and Atorvastatin Using Two Pills to an Equal Dose of Single-Pill Therapy in Japanese Outpatients
【24h】

Effects of Switching from Treatment with Amlodipine and Atorvastatin Using Two Pills to an Equal Dose of Single-Pill Therapy in Japanese Outpatients

机译:用两种药丸用两种丸剂治疗与阿托伐他汀治疗对日本门诊病人单丸治疗的影响

获取原文

摘要

This study examined whether switching from amlodipine and atorvastatin treatment using two pills to an equal dose of single-pill therapy is useful in Japanese outpatients. We retrospectively reviewed data obtained from 94 outpatients for whom treatment with two pills, namely amlodipine and atorvastatin, was switched to an equal dose of single-pill therapy in 11 hospitals. The criterion for enrollment in this study was that patients had switched their medication without changing other anti-hypertensive or anti-cholesterol drugs. Neither systolic nor diastolic blood pressure changed significantly after switching to an equal dose of single-pill therapy, whereas low-density lipoprotein (LDL) cholesterol levels significantly decreased after the medication was switched from 94±24 mg/dl to 89±17 mg/dl (p=0.015). A switch from medication with two separate pills of amlodipine and atorvastatin to an equal dose of single-pill therapy resulted in an overall decrease in LDL cholesterol. The results indicated that the switch to single-pill therapy might be a useful treatment.
机译:本研究检测了使用两种药丸从氨氯地平和阿托伐他汀治疗转换为平等剂量的单丸治疗可用于日本门诊病。我们回顾性地审查了从94个除药物治疗中获得的数据,即氨氯地脂素和阿托伐他汀的治疗,转换为11家医院的同等剂量单丸治疗。本研究报告的标准是患者在不改变其他抗高血压或抗胆固醇药物的情况下切换了药物。切换到平等剂量的单丸治疗后,收缩期和舒张压血压都没有显着变化,而药物从94±24 mg / dl切换到89±17 mg /时,低密度脂蛋白(LDL)胆固醇水平显着降低。 DL(p = 0.015)。用两种单独的氨氯堇和阿托伐他汀和阿托伐他汀的用药切换到平等剂量的单丸治疗导致LDL胆固醇的总体减少。结果表明,切换到单丸治疗可能是有用的治疗方法。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号